Aakash Desai: Breakthrough device designation for the first AI-driven companion diagnostic in NSCLC
Apr 30, 2025, 07:24

Aakash Desai: Breakthrough device designation for the first AI-driven companion diagnostic in NSCLC

Aakash Desai, Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared a post on X:

“Breakthrough Device Designation for the first AI-driven companion diagnostic in NSCLC!
VENTANA TROP2 RxDx Device by Roche uses AI + digital pathology to deliver diagnostic precision beyond manual scoring.
Big step forward in precision oncology.”

Aakash Desai: Breakthrough device designation for the first AI-driven companion diagnostic in NSCLC

More posts featuring NSCLC.